Tocqueville Asset Management’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q1 | – | Sell |
-66,460
| Closed | -$8.13M | – | 850 |
|
|
2016
Q4 | $8.13M | Buy |
66,460
+21,135
| +47% | +$2.59M | 0.1% | 218 |
|
|
2016
Q3 | $5.55M | Buy |
45,325
+6,090
| +16% | +$746K | 0.07% | 263 |
|
|
2016
Q2 | $4.58M | Sell |
39,235
-22,875
| -37% | -$2.67M | 0.05% | 304 |
|
|
2016
Q1 | $8.65M | Buy |
62,110
+12,520
| +25% | +$1.74M | 0.11% | 201 |
|
|
2015
Q4 | $9.46M | Sell |
49,590
-950
| -2% | -$181K | 0.13% | 185 |
|
|
2015
Q3 | $7.9M | Buy |
50,540
+6,315
| +14% | +$988K | 0.11% | 228 |
|
|
2015
Q2 | $8M | Buy |
44,225
+2,150
| +5% | +$389K | 0.09% | 235 |
|
|
2015
Q1 | $7.29M | Buy |
42,075
+160
| +0.4% | +$27.7K | 0.09% | 253 |
|
|
2014
Q4 | $7.76M | Sell |
41,915
-2,025
| -5% | -$375K | 0.08% | 243 |
|
|
2014
Q3 | $7.29M | Buy |
43,940
+575
| +1% | +$95.3K | 0.08% | 242 |
|
|
2014
Q2 | $6.78M | Buy |
43,365
+3,800
| +10% | +$594K | 0.07% | 270 |
|
|
2014
Q1 | $6.02M | Sell |
39,565
-3,440
| -8% | -$523K | 0.08% | 228 |
|
|
2013
Q4 | $5.72M | Buy |
43,005
+1,300
| +3% | +$173K | 0.08% | 234 |
|
|
2013
Q3 | $4.84M | Buy |
41,705
+1,715
| +4% | +$199K | 0.06% | 303 |
|
|
2013
Q2 | $3.69M | Buy |
+39,990
| New | +$3.69M | 0.05% | 327 |
|